Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ)
CNY 18.05
(-0.55%)
CNY 18.05
(-0.55%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.47 Billion | 3.15 Billion | 3.65 Billion | 2.26 Billion | 1.94 Billion | 2.01 Billion |
| Cost of Revenue | 655.29 Million | 499.94 Million | 986.42 Million | 226.3 Million | 163.67 Million | 179.41 Million |
| Gross Profit | 2.82 Billion | 2.65 Billion | 2.66 Billion | 2.03 Billion | 1.77 Billion | 1.83 Billion |
| Operating Expenses | 1.99 Billion | 2.02 Billion | 1.07 Billion | 1.29 Billion | 1.1 Billion | 1.32 Billion |
| Selling, General and Administrative Expenses | 1.51 Billion | 1.14 Billion | 643.74 Million | 913.83 Million | 816.05 Million | 1.04 Billion |
| Research and Development Expenses | 500.74 Million | 801.85 Million | 354.26 Million | 267.06 Million | 198.26 Million | 177.82 Million |
| Other Expenses | 234.26 Million | 74.4 Million | 73.92 Million | 110.47 Million | 92.98 Million | 7.82 Million |
| Cost and Expenses | 2.52 Billion | 2.52 Billion | 2.05 Billion | 1.51 Billion | 1.27 Billion | 1.5 Billion |
| Operating Income | 948.91 Million | 747.02 Million | 1.45 Billion | 775.37 Million | 657.81 Million | 481.25 Million |
| Interest Expense | 113.71 Million | 108.97 Million | 54.51 Million | 2.33 Million | 8.93 Million | 23.93 Million |
| Income Tax Expense | 79.01 Million | -205.53 Million | 175.86 Million | 93.22 Million | 88.94 Million | 53.4 Million |
| Earnings before Tax | 940.31 Million | -338.24 Million | 1.43 Billion | 772.41 Million | 663.44 Million | 489.08 Million |
| Net Income | 861.3 Million | -132.7 Million | 1.26 Billion | 679.18 Million | 574.5 Million | 435.68 Million |
| Earnings Per Share Basic | 0.77 | -0.12 | 1.16 | 0.64 | 0.57 | 0.44 |
| Earnings Per Share Diluted | 0.77 | -0.12 | 1.14 | 0.63 | 0.56 | 0.44 |
| Weighted Average Shares Outstanding | 1.11 Billion | 1.1 Billion | 1.09 Billion | 1.05 Billion | 1.01 Billion | 995.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.11 Billion | 1.1 Billion | 1.11 Billion | 1.07 Billion | 1.02 Billion | 995.85 Million |
| Gross Margin | 0.81 | 0.84 | 0.73 | 0.90 | 0.92 | 0.91 |
| EBIT Margin | 0.37 | 0.30 | 0.58 | 0.39 | 0.40 | 0.29 |
| Profit Margin | 0.25 | -0.04 | 0.35 | 0.30 | 0.30 | 0.22 |
| EBITDA | 1.29 Billion | 442.97 Thousand | 1.89 Billion | 881.55 Million | 756.75 Million | 572.24 Million |
| Earnings Before Tax Margin | 0.27 | 0.24 | 0.40 | 0.34 | 0.34 | 0.24 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 816.13 Million | 739.51 Million | 448.89 Million | 3.45 Billion | 1 Billion | 733.89 Million |
| Cost of Revenue | 139 Million | 164.12 Million | 71.96 Million | 622.75 Million | 220.78 Million | 114.42 Million |
| Gross Profit | 677.12 Million | 575.38 Million | 376.93 Million | 2.82 Billion | 781.75 Million | 619.46 Million |
| Operating Expenses | 444.26 Million | 501.44 Million | 353.86 Million | 2.05 Billion | 654.17 Million | 426.37 Million |
| Selling, General and Administrative Expenses | 493.73 Million | 338.17 Million | 245.91 Million | - | 449.94 Million | 391.96 Million |
| Research and Development Expenses | 91.58 Million | 95.32 Million | 107.6 Million | - | 129.47 Million | 113.69 Million |
| Other Expenses | -141.05 Million | -67.94 Million | -345.73 Thousand | -118.78 Million | -74.75 Million | -1.15 Million |
| Cost and Expenses | 583.27 Million | 665.56 Million | 425.82 Million | 2.67 Billion | 874.95 Million | 540.8 Million |
| Operating Income | 198.43 Million | 73.94 Million | 23.06 Million | 774.82 Million | 127.58 Million | 202.39 Million |
| Interest Expense | 29.56 Million | 30.74 Million | 32.77 Million | 113.71 Million | 29.82 Million | 28.37 Million |
| Income Tax Expense | 12.04 Million | -39.79 Million | 11.13 Million | 79.01 Million | 11.06 Million | 14.62 Million |
| Earnings before Tax | 197.77 Million | 71.53 Million | 65.15 Million | 940.31 Million | 175.31 Million | 201.24 Million |
| Net Income | 185.75 Million | 111.27 Million | 54.06 Million | 861.3 Million | 164.25 Million | 186.61 Million |
| Earnings Per Share Basic | 0.17 | 0.10 | 0.05 | - | 0.15 | 0.17 |
| Earnings Per Share Diluted | 0.17 | 0.10 | 0.05 | - | 0.15 | 0.17 |
| Weighted Average Shares Outstanding | 1.11 Billion | 1.11 Billion | 1.11 Billion | 1.11 Billion | 1.11 Billion | 1.11 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.11 Billion | 1.11 Billion | 1.11 Billion | 1.11 Billion | 1.11 Billion | 1.11 Billion |
| Gross Margin | 0.83 | 0.78 | 0.84 | 0.82 | 0.78 | 0.84 |
| EBIT Margin | 0.28 | 0.21 | 0.25 | - | 0.20 | 0.30 |
| Profit Margin | 0.23 | 0.15 | 0.12 | 0.25 | 0.16 | 0.25 |
| EBITDA | 227.33 Million | 152.44 Million | 110.06 Million | - | 197.21 Million | 220.84 Million |
| Earnings Before Tax Margin | 0.24 | 0.10 | 0.05 | 0.22 | 0.13 | 0.28 |
9408
ALBON
WWTIF
AMAG
TVT
CRR